Enlist Evaluating Nulojix Long-Term Safety In Transplant Trademark Details

Enlist Evaluating Nulojix Long-Term Safety in Transplant was registered on Tuesday, December 3, 2013 and is currently owned by Bristol-Myers Squibb Company under the registration number 4444220 . This mark is alive with a status of Registered. The last case file activity for this mark occured 10 years ago on Tuesday, December 3, 2013, according to the United State Patent & Trademark Office
Word Mark Enlist Evaluating Nulojix Long-Term Safety in Transplant
Status Alive Registered 700 — Registered

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 85328604
Registration Number 4444220
Status Date Tuesday, December 3, 2013
Filing Date Tuesday, December 3, 2013
Registration Date Tuesday, December 3, 2013
Attorney Marilyn Kelly

Correspondent

Marilyn F. Kelly
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT. - MAILSTOP D33-05
P.O. BOX 4000
PRINCETON NJ 08648-4000

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Evaluating" or "Long-Term Safety in Transplant"
Description of Mark The mark consists of the word "ENLIST" with the letter "N" enclosed in a circle followed by the wording "EVALUATING NULOJIX LONG-TERM SAFETY IN TRANSPLANT" underneath.
Goods & Services Providing an online computer database featuring a registry of medical information regarding safety in organ transplants

Classifications

International Class Codes
044 — Class 44 includes mainly medical care, hygienic and beauty care given by persons or establishments to human beings and animals; it also includes services relating to the fields of agriculture, horticulture and forestry.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Wednesday, November 2, 2011
First Use Anywhere Thursday, June 16, 2011
First Use In Commerce Thursday, June 16, 2011
Primary Code 044

You must be signed in to print.

Once signed in, look for the PDF button.